To hear about similar clinical trials, please enter your email below
Trial Title:
Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a National Registry-based Study
NCT ID:
NCT06350370
Condition:
Colorectal Cancer
Conditions: Official terms:
Colorectal Neoplasms
Conditions: Keywords:
Colorectal cancer
Natural orifice specimen extraction surgery
Minimally invasive surgery
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Treatment
Masking:
None (Open Label)
Intervention:
Intervention type:
Procedure
Intervention name:
Natural orifice specimen extraction
Description:
We perform laparoscopic colorectal cancer resection, intracorporeal anastomosis and
transanal or transvaginal specimen extraction
Arm group label:
NOSES group
Summary:
Natural orifice specimen extraction surgery (NOSES) has gained widespread recognition
among scholars and has gradually been promoted and popularized around the world. However,
the development of NOSES is still in the exploratory stage and there is a lack of strong
evidence from evidence-based medicine to support its feasibility and safety, which has
greatly affected its clinical application and development. Based on this, at the call of
Professor Xishan Wang, the Chinese NOSES Alliance conducted a large retrospective
clinical study involving multiple centers. By summarizing the NOSES cases of nearly 100
centers in China, the study aims to clarify the current status of NOSES surgery in China.
Additionally, a comprehensive analysis and summary was conducted by combining the basic
information of NOSES patients, perioperative data, postoperative pathological data, and
follow-up information to further demonstrate the safety and feasibility of NOSES in the
treatment of colorectal cancer. This study also provides more real and objective
evidence-based medicine support for the promotion and development of NOSES surgery.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
1. Pathological diagnosis of primary malignant tumor in the colon or rectum;
2. The surgery meets the definition in the "Consensus of NOSES Experts in Colorectal
Cancer";
Exclusion Criteria:
1. Postoperative pathological diagnosis does not belong to primary malignant tumors in
the colon or rectum;
2. The surgery does not meet the definition in the "Consensus of NOSES Experts in
Colorectal Cancer".
Gender:
All
Minimum age:
18 Years
Maximum age:
75 Years
Healthy volunteers:
No
Locations:
Facility:
Name:
Cancer Hospital Chinese Academy of Medical Sciences
Address:
City:
Beijing
Zip:
100021
Country:
China
Status:
Recruiting
Contact:
Last name:
Xishan Wang
Phone:
13261967603
Email:
wxshan_cams@163.com
Contact backup:
Last name:
Mingguang Zhang
Phone:
+8613261967603
Email:
zmgslimshady@163.com
Investigator:
Last name:
Xishan Wang, M.D.
Email:
Principal Investigator
Start date:
January 1, 2019
Completion date:
January 1, 2028
Lead sponsor:
Agency:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Agency class:
Other
Source:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06350370
